Biotec has opened a formulations facility for 'soft gelatin
capsules' at its Baddi complex, in Solan , Himachal Pradesh.
The new facility has an annual capacity of around 150
million capsules on single shift basis.
is the second expansion of the company in this year.
in April this year, the company had started production
of oral dosage forms with an annual capacity of 900 million
tablets: 12 million ointment tubes, 120 million hard gelatin
capsules and 12 million bottles of oral liquids at Baddi.
Biotec is a leading research-based pharmaceutical company,
with an annual turnover of nearly Rs350 crore. The company
manufactures and markets vaccines, bio-pharmaceutical
and pharmaceutical (prescription and OTC) products of
international quality. Panacea Biotec plants are accredited
by international agencies and they follow current good
manufacturing practices, as per WHO guidelines.
world class facility complies with US FDA and UK MHRA
requirements. This new dosage form of soft gelatin capsules
is a new addition to the Baddi facility. It will be used
to manufacture products, viz, Panimum Bioral (Cyclosporine)
etc, intended for the developed markets and Latin America,
in addition to the domestic market", Rajesh Jain,
joint managing director of the company, said.
also announced the opening of a new marketing office at
Saki Naka (Andheri), in Mumbai. "The new marketing
office would look after domestic as well as international
markets", said Mr. Jain.
company has already shifted corporate level marketing
activities of its three strategic business units (SBUs),
viz, Procare, Growcare and DiaCar, from Delhi to Mumbai.